Anne d’Andon
Impact in
- Economics and Econometrics top 5%
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Economic and Financial Impacts of Cancer
- Statistics and Probability top 10%
- Statistical Methods in Clinical Trials
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 12
- Pharmaceutical Economics and Policy 11
- Economic and Financial Impacts of Cancer 4
-
- Healthcare Systems and Practices 4
- Co-authors
- Wim Goettsch (3 shared papers)Anthonius de Boer (3 shared papers)Hans L. Hillege (1 shared paper)Amr Makady (1 shared paper)Páll Jónsson (1 shared paper)Olaf H. Klungel (1 shared paper)Belén Corbacho (1 shared paper)Elisabeth George (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Annals of Oncology (2 papers)Value in Health (2 papers)PharmacoEconomics (1 paper)International Journal of Technology Assessment in Health Care (1 paper)
- Partner nations
- FranceNetherlandsUnited Kingdom
In The Last Decade
Anne d’Andon
19 papers receiving 235 citations
Peers
Comparison fields: 5 of 63
- Economics and Econometrics 181
- Statistics and Probability 35
- Medical Laboratory Technology 4
- Geriatrics and Gerontology 9
- General Health Professions 51
Countries citing papers authored by Anne d’Andon
This map shows the geographic impact of Anne d’Andon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne d’Andon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne d’Andon more than expected).
Fields of papers citing papers by Anne d’Andon
This network shows the impact of papers produced by Anne d’Andon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne d’Andon. The network helps show where Anne d’Andon may publish in the future.
Co-authors
The 25 scholars most cited alongside Anne d’Andon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 75 | |
| 2 | 2012 | 47 | |
| 3 | 2016 | 44 | |
| 4 | 2019 | 24 | |
| 5 | 2013 | 12 | |
| 6 | 2005 | 9 | |
| 7 | 2013 | 8 | |
| 8 | 2017 | 5 | |
| 9 | 2012 | 2 | |
| 10 | 2012 | 2 | |
| 11 | 2017 | 2 | |
| 12 | 2017 | 2 | |
| 13 | 2016 | 2 | |
| 14 | 2019 | 1 | |
| 15 | 2016 | 1 | |
| 16 | 2017 | 1 | |
| 17 | 2017 | 1 | |
| 18 | 2019 | 1 | |
| 19 | 2016 | 1 | |
| 20 | 2003 | 1 |
About Anne d’Andon
Anne d’Andon is a scholar working on Economics and Econometrics, General Health Professions, Geriatrics and Gerontology, Pediatrics, Perinatology and Child Health and Radiology, Nuclear Medicine and Imaging, having authored 20 papers that have together received 241 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (12 papers), Pharmaceutical Economics and Policy (11 papers), Economic and Financial Impacts of Cancer (4 papers), Healthcare Systems and Practices (4 papers), Pharmaceutical Practices and Patient Outcomes (3 papers), Pharmaceutical studies and practices (2 papers), Biosimilars and Bioanalytical Methods (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Economics and Econometrics (181 citations), Statistics and Probability (35 citations), Medical Laboratory Technology (4 citations), Geriatrics and Gerontology (9 citations) and General Health Professions (51 citations). Anne d’Andon has collaborated with scholars based in France, Netherlands and United Kingdom. Frequent co-authors include Wim Goettsch, Anthonius de Boer, Hans L. Hillege, Amr Makady, Páll Jónsson, Olaf H. Klungel, Belén Corbacho, Elisabeth George, Steffen Thirstrup and Hubert G. M. Leufkens. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Value in Health, PharmacoEconomics and International Journal of Technology Assessment in Health Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.